TC BioPharm Files 6-K Report
Ticker: TCBWF · Form: 6-K · Filed: May 27, 2025 · CIK: 1872812
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, regulatory-filing
TL;DR
TC BioPharm (Holdings) plc filed a 6-K, standard procedure for foreign issuers.
AI Summary
TC BioPharm (Holdings) plc filed a Form 6-K on May 27, 2025, reporting as a foreign private issuer. The company, previously known as TC BioPharm (Holdings) Ltd and TC BioPharm Ltd, is based in Holytown, Scotland, and operates in the biological products sector.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding TC BioPharm's status as a foreign private issuer.
Risk Assessment
Risk Level: low — This filing is a routine disclosure for a foreign private issuer and does not contain new material financial or operational information.
Key Players & Entities
- TC BioPharm (Holdings) plc (company) — Filer
- TC BioPharm (Holdings) Ltd (company) — Former company name
- TC BioPharm Ltd (company) — Former company name
- Maxim 1, 2 Parklands Way, Holytown, Motherwell, ML1 4WR, Scotland, United Kingdom (location) — Principal Executive Offices
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, typically for reporting information that is made public in their home country.
When was TC BioPharm (Holdings) plc incorporated or last changed its name?
The company's name was changed from TC BioPharm (Holdings) Ltd on July 21, 2021, and prior to that, from TC BioPharm Ltd on July 14, 2021.
What is the primary business of TC BioPharm (Holdings) plc?
TC BioPharm (Holdings) plc is classified under the Standard Industrial Classification code 2836, which pertains to Biological Products (no diagnostic substances).
Does TC BioPharm file an annual report on Form 20-F or 40-F?
Yes, the registrant indicates it files annual reports under cover of Form 20-F.
What is the principal executive office address for TC BioPharm (Holdings) plc?
The principal executive offices are located at Maxim 1, 2 Parklands Way, Holytown, Motherwell, ML1 4WR, Scotland, United Kingdom.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 27, 2025 regarding TC BioPharm (Holdings) plc (TCBWF).